Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using AI to analyze heart transplant rejection through echocardiograms

Official title: Outcome Reflection for Immune Mediated Rejection by Utilizing Artificial Intelligence in Cardiac Transplant Patients Through Early and Late Echocardiographic Analysis (ORACLE)

Run by Mayo Clinic · NCT06178744 · Data updated 2026-11-12

This study is testing if an AI program can help doctors better spot heart transplant rejection by looking at echocardiograms and ECGs from patients who have had a heart transplant.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedApril 4, 2024
Main results expectedJune 2027
Study endsJune 2028
Registry record updatedJune 24, 2026
Trial IDNCT06178744 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients who have recently undergone a cardiac transplant and are scheduled for endomyocardial biopsy.

Probably not a fit

Patients who refuse to participate in the study will not benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to improve the detection of cardiac transplant rejection by utilizing an Artificial Intelligence (AI) algorithm that analyzes data from electrocardiograms (ECGs) and echocardiograms. The study will observe patients undergoing endomyocardial biopsy after cardiac transplant to assess the accuracy of the AI in distinguishing between rejection and non-rejection episodes. By leveraging advanced technology, the study seeks to enhance diagnostic capabilities in post-transplant care.

Why it matters

Potential benefit: If successful, this approach could lead to more accurate and timely detection of cardiac transplant rejection, improving patient outcomes.

How similar studies have gone: While the use of AI in medical diagnostics is a growing field, this specific application in cardiac transplant rejection detection is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing post-cardiac transplant endomyocardial biopsy, and the ability to provide informed consent and a consent for the study.

Exclusion Criteria:

* Refusal of study participation

Where it's running

  • Mayo Clinic in Rochester
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.